The present invention relates to a white blood cell capturing device.
DNA is damaged by the influence of radiation exposure or living environment. It has been considered that the damaged DNA is closely related to diseases such as cancers. A method which includes centrifuging blood to isolate white blood cells, staining the isolated white blood cells, and then observing on a glass slide has heretofore been adopted to analyze the damaged DNA.
A micro flow path for capturing fine particles such as white blood cells has heretofore been proposed (see Patent Document 1). Patent Document 1 discloses a micro flow path device which has a filter function for only capturing and separating solid particles having at least a predetermined size from a solid-liquid mixture using a micro flow path having concave capturing portions. Patent Document 1 aims at receiving one or more solid particles having at least a predetermined size in one capturing portion to completely capture solid particles having at least the predetermined size before the distal end of a separating part including the plurality of capturing portions disposed therein, and does not consider capturing only one solid particle in a single capturing portion so that the captured solid particle such as a white blood cell may be easily observed. Further, the solid-liquid mixture needs to flow at all times from an inlet of the micro flow path toward its outlet to prevent solid particles once captured in the capturing portions from refloating and flowing out of the capturing portions.
In the conventional method, however, red blood cells, proteins and the like are contained in a liquid from which white blood cells are to be captured, and their coagulates are often captured together with the white blood cells to cause noises when they are observed.
An object of the present invention is to solve the problem as described above. Specifically, an object of the present invention is to provide a white blood cell capturing device which captures white blood cells at a high degree of efficiency and is less likely to capture the other components.
The present invention provides the following (1) and (6).
(1) A white blood cell capturing device configured to capture white blood cells contained in a blood-containing liquid by passing the blood-containing liquid therethrough, the device including:
(2) The white blood cell capturing device according to (1) above, wherein the auxiliary part is identical in configuration to the main part.
(3) The white blood cell capturing device according to (1) or (2) above, wherein a width between the specific layer and the another layer adjacent thereto in the main part is 8 to 30 μm.
(4) The white blood cell capturing device according to any one of (1) to (3) above, wherein a ratio of a bypass portion width to a capturing portion width in the main part is more than 1 but not more than 3.
(5) The white blood cell capturing device according to any one of (1) to (4) above, wherein in the main part, portions of the protruding portions at their inlet side end faces except the capturing portions extend parallel to a layer direction, and end faces of the protruding portions constituting the bypass portions extend in a direction perpendicular to the layer direction.
(6) The white blood cell capturing device according to any one of (1) to (5) above, wherein the threshold diameter Dc is 5 μm or more but less than 10 μm.
The present invention can provide a white blood cell capturing device which captures white blood cells at a high degree of efficiency and is less likely to capture the other components.
The white blood cell capturing device of the invention will be described.
The white blood cell capturing device of the invention flows a blood-containing liquid having entered through an inlet toward an outlet by the action of a pump (syringe pump or the like), hydrostatic pressure, electroosmotic flow or the like. Then, during this process, white blood cells are moved from the interior of the blood-containing liquid into a buffer and thereafter captured by capturing portions located between protruding portions adjacent to each other in a main part.
The white blood cell capturing device of the invention can be fabricated by, for example, pouring rubber into a mold having a flow path pattern formed therein to obtain a flow path chip, and then attaching the obtained chip to a glass substrate.
The white blood cell capturing device of the invention will be described with reference to drawings.
The white blood cell capturing device 1 of the invention shown in
However, a cover covering an upper surface of the white blood cell capturing device 1 of the invention (which will be described later) is not shown in
The white blood cell capturing device of the invention which will be described below with reference to drawings is a preferred embodiment and is merely illustrative. The white blood cell capturing device of the invention should not be construed as being limited to the embodiment shown in the drawings.
The white blood cell capturing device 1 of the invention has a sample inlet 3, a buffer inlet 4, a white blood cell separation unit 10, a main part 50, an auxiliary part 70, and an outlet 9.
A blood-containing liquid X1 is introduced into the sample inlet 3.
The sample inlet 3 may be a hole where the introduced blood-containing liquid X1 can temporarily remain.
According to the embodiment shown in
A flow path 5 connects the sample inlet 3 to an inlet 10in of the white blood cell separation unit 10, and configuration is made so that the blood-containing liquid X1 having been introduced into the sample inlet 3 passes through the flow path 5 to be introduced into the interior of the white blood cell separation unit 10 from the inlet 10in.
The flow path 5 may be formed of, for example, a pillar. The pillar prevents the flow path 5 from getting clogged when a through-hole is formed in a flow path chip obtained by pouring rubber into a mold having a flow path pattern formed therein, and the flow path chip is attached to a glass substrate.
The blood-containing liquid X1 as used herein is not particularly limited as long as it is a liquid containing blood of animals including humans, and may be, for example, a liquid mixture obtained by adding human blood to a phosphate buffer solution (PBS), an anticoagulant, a stain solution, and the like. The blood-containing liquid may be blood itself of animals including humans.
A buffer Y1 is introduced into the buffer inlet 4.
The buffer inlet 4 may be a hole where the introduced buffer Y1 can temporarily remain.
According to the embodiment shown in
A flow path 6 connects the buffer inlet 4 to the inlet 10in of the white blood cell separation unit 10, and configuration is made so that the buffer Y1 having been introduced into the buffer inlet 4 passes through the flow path 6 to be introduced into the interior of the white blood cell separation unit 10 from the inlet 10in.
As with the flow path 5, the flow path 6 may be formed of, for example, a pillar.
The buffer Y1 is not particularly limited as long as it is a reagent for use in DNA damage analysis, and may be, for example, a phosphate buffer solution (PBS), paraformaldehyde (PFA), DAPI or the like.
The white blood cell separation unit 10 will be described with reference to
As shown in
As described above, in this example, the white blood cell capturing device is formed by attaching to a glass substrate a flow path chip obtained by pouring rubber into a mold having a flow path pattern formed therein, and the glass substrate constitutes the flat portion 11.
Further, the white blood cell separation unit 10 shown in
The blood-containing liquid X1 and the buffer Y1 flow on a surface 11S of the flat portion 11 and between the columns 13 adjacent to each other.
Further, as shown in
Further, the blood-containing liquid X1 and the buffer Y1 each form a generally laminar flow. In
This is mainly due to significantly reduced Reynolds numbers of the blood-containing liquid X1 and the buffer Y1.
The DLD is disclosed in Naotomo Tottori et al./three others, Development of Deterministic Lateral Displacement Device for Separation of Particles, Proceedings of 2015 Spring Meeting of the Japan Society for Precision Engineering, JSPE, 2015, pp. 743-744; and WO 2016/136273. The DLD is a technique for separating large-sized particles and small-sized particles from a flow of a liquid containing particles dispersed therein making use of a large number of columns regularly arranged in a microfluidic device.
As shown in
Then, white blood cells 20 move obliquely along the inclined lines of the columns 13. In contrast, small-sized particles 22 which are smaller in diameter than the white blood cells 20 move in a zig-zag manner with respect to the direction of flow (FX and the same direction Z) while changing the orientation of flow at the columns 13, but generally move in a linear manner along the laminar flow. Therefore, when the blood-containing liquid X1 and the buffer Y1 flow in the specific same direction Z on the flat portion 11 in the white blood cell capturing device 10 so as to be adjacent to each other, the white blood cells 20 in the blood-containing liquid X1 move to the side of the buffer Y1 to enter the interior of the buffer Y1 from the interface between the laminar flow of the blood-containing liquid X1 and that of the buffer Y1.
According to Development of Deterministic Lateral Displacement Device for Separation of Particles and WO 2016/136273, the threshold diameters Dc of the small-sized particles moving along the direction of flow of the blood-containing liquid X1 (FX and the same direction Z) and the large-sized particles moving obliquely are determined by formula 1 below:
According to WO 2016/136273, the threshold diameter Dc is determined by the following formula which is equivalent to formula 1.
Particles having diameters smaller than the threshold diameter Dc generally move along the direction of flow, while particles having diameters larger than the threshold diameter Dc move obliquely. As described above, the white blood cells 20 are larger in diameter than the other components. Therefore, the white blood cells 20 can be obliquely moved along the inclined lines of the columns 13 to reach the interior of the buffer Y1 by setting the threshold diameter Dc defined by Dc=1.4 g×(1/tan θ)−0.48 to be smaller than the diameter of the white blood cells but larger than that of the other particles (such as platelets) to be separated therefrom.
By setting the threshold diameter Dc to, for example, 5 μm or more but less than 10 μm, the threshold diameter Dc becomes smaller than the diameter of the white blood cells (about 10 to 20 μm) and larger than that of the other particles (such as platelets) to be separated therefrom, and the white blood cells can be separated with a high degree of efficiency.
In
The buffer Y1 containing the white blood cells separated as above from the blood-containing liquid X1 is hereinafter referred to as a buffer Y2.
The remainder of the blood-containing liquid X1 from which the white blood cells have been separated is hereinafter referred to as a blood-containing liquid X2.
Then, each of them is discharged from the white blood cell separation unit 10.
The buffer Y2 discharged from the white blood cell separation unit 10 is moved toward the main part to be described later.
The blood-containing liquid X2 discharged from the white blood cell separation unit 10 is moved toward the auxiliary part to be described later.
The main part 50 serves as a chip for capturing white blood cells contained in the buffer Y2 while passing the buffer Y2 therethrough.
The main part 50 is set with reference to
However, a cover covering an upper surface of the main part 50 (which will be described later) is not shown in
The main part 50 illustrated in
The configuration of the main part 50 is not limited to that illustrated in
As shown in
As described above, in this example, the white blood cell capturing device is formed by attaching to a glass substrate a flow path chip obtained by pouring rubber into a mold having a flow path pattern formed therein, and the glass substrate constitutes the flat portion 52.
Further, the main part 50 shown in
As shown in
Each layer contains a plurality of protruding portions 54.
The buffer Y2 having entered the main part 50 from the inlet 50in flows on a surface of the flat portion 52, and first passes through flow paths between the protruding portions 54 in the first layer and then passes through flow paths between the protruding portions 54 in the second layer. The device is configured so that the buffer Y2 flows thereafter in the same manner to pass through flow paths between the protruding portions 54 in the layer P, and then pass through flow paths between the protruding portions 54 in the layer P+1.
As shown in
In the example of
Further, a capturing portion 61 is located on the outlet side of a bypass portion 63 in a specific layer as a part of another layer adjacent thereto. That is, in the example of
As illustrated in
In the example shown in
In the plan views as shown in
Further, as illustrated in
When a part of each edge is linearly cut off to be chamfered, the angle of the line formed by chamfering is preferably 30 to 60° with respect to the direction perpendicular to the layer direction (direction from the inlet toward the outlet). In a case where chamfering is not linear but is, for example, spoon-shaped chamfering or round chamfering, the tangent line preferably forms an average angle of 30 to 60°. When this angle is smaller than 30°, white blood cells tend to flow into the bypass portions 63 at higher speeds to lower the capturing efficiency. When this angle is larger than 60°, the possibility that a plurality of white blood cells are captured in a single capturing portion 61 tends to be increased.
If a capturing portion 61 is gradually narrowed toward its bottom, both inlet side portions of two protruding portions constituting the capturing portion 61 may be chamfered or only one inlet side portion may be chamfered. When both the inlet side portions are chamfered, the chamfering angle may be the same or different.
In a case where the protruding portions 54 have a rectangular-based shape in which part of edges in four corners are (for example linearly or curvilinearly) cut off to be chamfered, other white blood cells that reached the capturing portions 61 already having white blood cells captured therein move in the layer direction along end faces of the protruding portions 54 and move from the bypass portions 63 to the adjacent layer on the downstream side, where the white blood cells are easily captured by the capturing portions 61 in the downstream side layer. Consequently, the inventors have found that the white blood cell capturing efficiency is increased.
As shown in
In particular, when as in the case shown in
In a case where the protruding portions 54 do not have a rectangular-based shape (in the case of a circular shape or an elliptical shape, for example), their outer shape contains R and white blood cells may therefore move along the R instead of moving to the capturing portions 61 in the adjacent layer on the downstream side.
Each of the capturing portions 61 has a width L1 of 2 to 7.5 μm, preferably 3 to 6 μm, and more preferably 4 to 5 μm.
Each of the bypass portions 63 has a width L2 of 8 to 20 μm, preferably 8.5 to 15 μm, and more preferably 9 to 10 μm.
Each of the width L1 and the width L2 means the shortest distance between one protruding portion 54 and its adjacent protruding portion 54 in each layer.
The ratio (L2/L1) of the width L2 of the bypass portions 63 to the width L1 of the capturing portions 61 is preferably more than 1 but not more than 3, and more preferably 1.5 to 2.5, because in this case, the flow toward the bypass portions 63 is adequately suppressed, thus facilitating capturing of white blood cells in the capturing portions.
The width L3 between the layer P and the layer P+1 is preferably 8 to 30 μm, and more preferably 9 to 10 μm.
The width L3 means the shortest distance between the layer P and the layer P+1.
The maximum width La of each capturing portion 61 at the chamfered portions on the inlet side is preferably 10 to 35 μm and more preferably 15 to 25 μm.
Each of the protruding portions 54 shown in
The auxiliary part 70 serves to pass the blood-containing liquid X2 discharged from the white blood cell separation unit 10 therethrough. The auxiliary part 70 is configured to have the same flow path resistance as the above-mentioned main part 50.
The same flow path resistance as used herein means that the difference between the pressure loss of the main part from its inlet to its outlet and that of the auxiliary part from its inlet to its outlet is within 20% (preferably within 10%) with respect to the higher pressure loss.
The auxiliary part 70 preferably has the same configuration as the above-mentioned main part 50, When the auxiliary part 70 is configured in the same manner as the above-mentioned main part 50, the flow path resistances to the buffer Y2 and the blood-containing liquid X2 are made identical, and as a result, the flow rates of the blood-containing liquid X1 and the buffer Y1 flowing in the white blood cell separation unit 10 can be controlled to be the same to increase the white blood cell separation efficiency in the white blood cell separation unit 10.
The white blood cell capturing device 1 of the invention preferably has a partition wall 80 between the main part 50 and the auxiliary part 70 for separating them from each other.
The shape or the like of the partition wall 80 is not particularly limited as long as it has the function of separating the main part 50 and the auxiliary part 70 from each other.
Liquids after having passed through the main part 50 and the auxiliary part 70 pass through a flow path 7 to be discharged from the outlet 9.
The outlet 9 may be a hole through which the liquids after having passed through the main part 50 and the auxiliary part 70 can be discharged.
According to the embodiment shown in
The flow path 7 connects the outlet 50out of the main part 50 and an outlet of the auxiliary part 70 to the outlet 9, and configuration is made so that the liquids discharged from the main part 50 and the auxiliary part 70 pass through the flow path 7 to reach the outlet 9.
The flow path 7 need only be formed of a member having the same function as the above-mentioned flow paths 5 and 6. The flow path 7 may be formed of, for example, a pillar.
As described above, the white blood cell capturing device 1 of the invention may be the one obtained by pouring rubber into a mold having a flow path pattern formed therein to obtain a flow path chip, and then attaching the obtained chip to a glass substrate. The size and the material of the flow path chip are not particularly limited. The flow path chip may be made of, for example, resins such as silicone rubber, acrylic resin, polycarbonate, cyclic olefin polymer, cyclic olefin copolymer, polystyrene, polyethylene, and polyethylene terephthalate. The substrate to which rubber is attached is preferably made of glass but may be made of a material other than glass.
The white blood cell capturing device of the invention as described above only separates white blood cells from a blood-containing liquid toward a buffer and then captures the white blood cells. In other words, when the white blood cells are captured, red blood cells, proteins and the like are not contained in the buffer containing them. Therefore, capturing of these coagulates and the like together with the white blood cells can be avoided. Accordingly, it is not necessary to remove unnecessary blood or clean the interiors of the flow paths.
First, silicone rubber (SILPOT184 manufactured by Dow Corning Corp.) was poured into a mold having a flow path pattern formed therein.
Next, the silicone rubber was vulcanized under conditions of 120° C. and 30 minutes.
Next, the silicon rubber was peeled off from the silicon wafer to form a chip having flow paths formed therein.
Next, a punch was used to form holes serving as the sample inlet 3, the buffer inlet 4, and the outlet 9, respectively.
The chip having the flow paths formed therein which was perforated as described above and a glass substrate were both irradiated with vacuum ultraviolet light (L12530-01 manufactured by Hamamatsu Photonics K.K.) for 15 seconds. Then, the irradiated surfaces were bonded together to obtain the white blood cell capturing device 1 of the invention shown in
Peripheral blood obtained from an adult male wad diluted 10 times with PBS to obtain the blood-containing liquid X1. PBS was used as the buffer Y1.
Next, the blood-containing liquid X1 was dropped into the sample inlet 3 and the buffer Y1 was dropped into the buffer inlet 4.
Next, the liquids were made to flow by the negative pressure of a syringe pump from the outlet 9.
Then, the state of flow of the liquids was checked by a microscope. A micrograph (combination of a 10× ocular lens and a 10× objective lens) is shown in
The liquids were continuously made to flow for further 30 minutes but clogging of the flow path in the main part 50 was not seen.
It was also revealed that the white blood cells were captured in the main part 50.
This application claims priority based on Japanese Patent Application No. 2022-51142 filed on Mar. 28, 2022, the entire disclosure of which is incorporated herein by reference.
Number | Date | Country | Kind |
---|---|---|---|
2022-051142 | Mar 2022 | JP | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/JP2023/007099 | 2/27/2023 | WO |